Francisco España
Francisco España
Hospital Universitario La Fe
Centro de Investigación
Av. Campanar 21
E-mail:
Name/email consistency: medium
- Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levels. Medina, P., Bonet, E., Navarro, S., Martos, L., Estellés, A., Ferrando, F., Vicente, V., Bertina, R.M., España, F. Thromb. Haemost. (2012)
- The role of protein C inhibitor in human reproduction. España, F., Navarro, S., Medina, P., Zorio, E., Estellés, A. Semin. Thromb. Hemost. (2007)
- The multifunctional protein C system. Espana, F., Medina, P., Navarro, S., Zorio, E., Estellés, A., Aznar, J. Curr. Med. Chem. Cardiovasc. Hematol. Agents (2005)
- Changes in molecular forms of prostate-specific antigen during treatment with finasteride. España, F., Martínez, M., Royo, M., Estellés, A., Alapont, J.M., Navarro, S., Aznar, J., Jiménez-Cruz, J.F. BJU Int. (2002)
- Inherited abnormalities in the protein C activation pathway. España, F., Medina, P., Navarro, S., Estellés, A., Aznar, J. Pathophysiol. Haemost. Thromb. (2002)
- Low level of circulating activated protein C is a risk factor for venous thromboembolism. España, F., Vayá, A., Mira, Y., Medina, P., Estellés, A., Villa, P., Falcó, C., Aznar, J. Thromb. Haemost. (2001)